Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2015-05-21

Clinical Trial Update: Nepal Elimination of Trachoma Study [Phase 2, Phase 3]

View source ↗

Summary

This document notes that the Nepal Elimination of Trachoma Study, a Phase 2/Phase 3 clinical trial, has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: University of California, San Francisco | Conditions: Trachoma | Phase 2, Phase 3 | Status: WITHDRAWN